Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs
Next-generation weight-loss drugs just hit a new milestone: In a phase 3 clinical trial, retatrutide helped people with type 2 diabetes lose an average of up to 49.6 pounds, or.

